Regulation of eosinophil apoptosis by nitric oxide: Role of c-Jun-N-terminal kinase and signal transducer and activator of transcription 5

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 1, 2003, Pages 93-101

  Zhang, Xianzhi ^a   Moilanen, Eeva ^a,b   Lahti, Aleksi ^a   Hämäläinen, Mari ^a   Giembycz, Mark A ^c   Barnes, Peter J ^c   Lindsay, Mark A ^d   Kankaanranta, Hannu ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d ASTRAZENECA   (United Kingdom)

Author keywords

Apoptosis; c Jun N terminal kinase; Caspases; cGMP; Eosinophils; Nitric oxide; STAT5

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIC GMP; DNA FRAGMENT; GUANYLATE CYCLASE; INTERLEUKIN 5; LIPOCORTIN 5; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM SALT; STAT5 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL ISOLATION; CELL SURVIVAL; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MORPHOLOGY; PRIORITY JOURNAL;

EID: 0037662016     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1587     Document Type: Article

References (45)

1. Giembycz MA, Lindsay MA. Pharmacology of the cosinophil. Pharmacol Rev 1999;51:213-340.
2. Barnes PJ. Pathophysiology of asthma. Br J Clin Pharmacol 1996;42:3-10.
3. Simon HU. Eosinophil apoptosis in allergic diseases - an emerging new issue. Clin Exp Allergy 1998;28:1321-4.
4. Walsh GM. Human eosinophils: their accumulation, activation and fate. Br J Haematol 1997;97:701-9.
5. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
6. Kankaanranta H, Lindsay MA, Giembycz MA, Zhang X, Moilanen E, Barnes PJ. Delayed eosinophil apoptosis in asthma. J Allergy Clin Immunol 2000;106:77-83.
7. Wedi B, Raap U, Lewrick H, Kapp A. Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J Allergy Clin Immunol 1997;100:536-43.
8. Vignola AM, Chanez P, Chiappara G, Siena L, Merendino A, Reina C, et al. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol 1999;103:563-73.
9. Moilanen E, Whittle B, Moncada S. Nitric oxide as a factor in inflammation. In: Gallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 787-800.
10. Pieper AA, Verma A, Zhang J, Snyder SH. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 1999;20:171-81.
11. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 2001;282:1075-9.
12. Coleman JW. Nitric oxide in immunity and inflammation. Int Immunopharmacol 2001;1:1397-406.
13. Kharitonov SA, Barnes PJ. Does exhaled nitric oxide reflect asthma control? Yes, it does! Am J Respir Crit Care Med 2001;164:727-8.
14. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000;162:701-6.
15. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-3.
16. del Pozo V, de Arruda-Chaves E, de Andres B, Cardaba B, Lopez-Farre A, Gallardo S, et al. Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. J Immunol 1997;158:859-64.
17. Hebestreit H, Dibbert B, Balatti I, Braun D, Schapowal A, Blaser K, et al. Disruption of fas receptor signaling by nitric oxide in eosinophils. J Exp Med 1998;187:415-25.
18. Kankaanranta H, De Souza PM, Barnes PJ, Salmon M, Giembycz MA; Lindsay, et al. SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils. J Pharm Exp Ther 1999;290:621-8.
19. Zhang X, Moilanen E, Adcock IM, Lindsay MA, Kankaanranta H. Divergent effect of mometasone on human eosinophil and neutrophil apoptosis. Life Sci 2002;71:1523-34.
20. Kankaanranta H, De Souza PM, Giembycz MA, Lindsay MA. Human eosinophil isolation and the measurement of apoptosis. In: Chung KF, Adcock IM, editors. Methods in molecular medicine: asthma. Vol 44. London: Humana Press; 2000. p. 99-110.
21. Korhonen R, Korpela R, Saxelin M, Maki M, Kankaanranta H, Moilanen E. Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation 2001;25:223-32.
22. Moilanen E, Moilanen T, Knowles R, Charles I, Kadoya Y, al-Saffar N, et al. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol 1997;150:881-7.
23. Kankaanranta H, Rydell E, Petersson AS, Holm P, Moilanen E, Corell T, et al. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br J Pharmacol 1996;117:401-6.
24. Maeda H, Akaike T, Yoshida M, Suga M. Multiple functions of nitric oxide in pathophysiology and microbiology: analysis by a new nitric oxide scavenger. J Leukoc Biol 1994;56:588-92.
25. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 2001;50:77-82.
26. Ishihara K, Satoh I, Mue S, Ohuchi K. Possible participation of a JAK2 signaling pathway in recombinant rat interleukin-5-induced prolongation of rat eosinophil survival. Biochim Biophys Acta 2001;1536:73-84.
27. Zangrilli J, Robertson N, Shetty A, Wu J, Hastie A, Fish JE, et al. Effect of IL-5, glucocorticoid, and Fas ligation on Bcl-2 homologue expression and caspase activation in circulating human eosinophils. Clin Exp Immunol 2000;120:12-21.
28. Dewson G, Walsh GM, Wardlaw AJ. Expression of Bcl-2 and its homologues in human eosinophils. Modulation by interleukin-5. Am J Respir Cell Mol Biol 1999;20:720-8.
29. Dibbert B, Daigle I, Braun D, Schranz C, Weber M, Blaser K, et al. Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood 1998;92:778-83.
30. Beauvais F, Joly F. Effects of nitric oxide on the eosinophil survival in vitro. A role for nitrosyl-heme. FEBS Lett 1999;443:37-40.
31. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239-52.
32. Jun CD, Pae HO, Kwak HJ, Yoo JC, Choi BM, Oh CD, et al. Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways. Cell Immunol 1999;194:36-46.
33. Jun CD, Oh CD, Kwak HJ, Pae HO, Yoo JC, Choi BM, et al. Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways. J Immunol 1999;162:3395-401.
34. Clancy R, Rediske J, Koehne C, Stoyanovsky D, Amin A, Attur M, et al. Activation of stress-activated protein kinase in osteoarthritic cartilage: evidence for nitric oxide dependence. Osteoarthritis Cartilage 2001;9:294-9.
35. Ammendrup A, Maillard A, Nielsen K, Aabenhus AN, Serup P, Dragsbaek MO, et al. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes 2000;49:1468-76.
36. Chae HJ, So HS, Chae SW, Park JS, Kim MS, Oh JM, et al. Sodium nitroprusside induces apoptosis of H9C2 cardiac muscle cells in a c-Jun N-terminal kinase-dependent manner. Int Immunopharmacol 2001;1:967-78.
37. Taimor G, Rakow A, Piper HM. Transcription activator protein 1 (AP-1) mediates NO-induced apoptosis of adult cardiomyocytes. FASEB J 2001;15:2518-20.
38. Chung KC, Park JH, Kim CH, Ahn YS. Tumor necrosis factor-alpha and phorbol 12-myristate 13-acetate differentially modulate cytotoxic effect of nitric oxide generated by serum deprivation in neuronal PC12 cells. J Neurochem 1999;72:1482-8.
39. Adachi T, Alam R. The mechanism of IL-5 signal transduction. Am J Physiol 1998;275:C623-C633
40. de Groot RP, Coffer PJ, Koenderman L. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal 1998;10:619-28.
41. Hall DJ, Cui J, Bates ME, Stout BA, Koenderman L, Coffer PJ, et al. Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability. Blood 2001;98:2014-21.
42. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-6.
43. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000;157:1415-30.
44. Daigle I, Simon HU. Critical role for caspases 3 and 8 in neutrophil but not eosinophil apoptosis. Int Arch Allergy Immunol 2001;126:147-56.
45. Zhang JP, Wong CK, Lam CW. Role of caspases in dexamethasone-induced apoptosis and activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils. Clin Exp Immunol 2000;122:20-7.